First County Bank CT Sells 1,651 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

First County Bank CT reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 68.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 754 shares of the healthcare conglomerate's stock after selling 1,651 shares during the quarter. First County Bank CT's holdings in UnitedHealth Group were worth $395,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth about $32,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on UNH shares. Barclays reduced their price objective on UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Argus cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. Truist Financial restated a "buy" rating and set a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $441.87.

Insider Buying and Selling

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 in the last quarter. Insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Up 1.0%

UnitedHealth Group stock traded up $2.91 during midday trading on Friday, reaching $301.08. The stock had a trading volume of 16,265,624 shares, compared to its average volume of 6,787,922. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a fifty day moving average price of $430.87 and a two-hundred day moving average price of $494.23. The company has a market capitalization of $273.12 billion, a P/E ratio of 19.42, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the business earned $6.91 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.